Screener
Mirum Pharmaceuticals, Inc. MIRM Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Exchange and repurchase of 2029 convertible notes | (474,365) | — |
| Proceeds from issuance of common stock and pre-funded warrants in private placement, net of issuance costs of $8,600 | 259,948 | — |
| Proceeds from issuance of common stock pursuant to equity plans | 23,499 | 15,047 |
| Net cash provided by financing activities | 481,517 | 15,047 |
| Effect of exchange rate on cash, cash equivalents and restricted cash | (2,645) | 3,281 |
| Net increase in cash, cash equivalents and restricted cash | 34,297 | 5,674 |
| Cash, cash equivalents and restricted cash at beginning of period | 298,165 | 222,928 |
| Cash, cash equivalents and restricted cash at end of period | $332,462 | $228,602 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Mirum Pharmaceuticals, Inc.'s net change in cash?
- Mirum Pharmaceuticals, Inc. (MIRM) reported net change in cash of $5.82M in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s net change in cash changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s net change in cash decreased by 64.4% year-over-year, from $16.36M to $5.82M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s net change in cash?
- Over 2 years (2022 to 2025), Mirum Pharmaceuticals, Inc.'s net change in cash has grown at a 374.8% compound annual growth rate (CAGR), from -$3.34M to $75.24M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Mirum Pharmaceuticals, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude